Liquid Grids competitors

Liquid Grids's competitors include LGC Biosearch Technologies, Loxo Oncology, Fate Therapeutics and Parexel International

Add company...

Save Comparison Clear all	Liquid Grids Liquid Grids empowers healthcare companies to listen, understand, and strategically engage in online health dialogues.	LGC Biosearch Technologies LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.	Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.	Fate Therapeutics Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.	Parexel International Parexel International is a biopharmaceutical outsourcing services company.
Founding Date	Founding Date 2010	Founding Date 1842	Founding Date 2013	Founding Date 2007	Founding Date 1983
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech lifestyle pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations San Diego, US HQ	Locations Teddington, GB HQ	Locations Stamford, US HQ South San Francisco, US	Locations San Diego, US HQ	Locations Waltham, US HQ Vicente López, AR Macquarie Park, AU Wavre, BE Centro, BR Pudong Xinqu, CN Guangzhou, CN see more
Employees	Employees 10	Employees N/A	Employees 4757% increase	Employees 66	Employees 18,9002% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 4.8 b	Valuation ($) 651.7 m	Valuation ($) 4.6 b
Facebook likes	Facebook likes 2	Facebook likes 1.1 k	Facebook likes N/A	Facebook likes N/A	Facebook likes 6.5 k
Twitter followers	Twitter followers 1.4 k	Twitter followers 2.4 k	Twitter followers 46	Twitter followers 853	Twitter followers 8.3 k
Financial ⚠
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £108.1m (FY, 2017)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.4b (FY, 2016)
Net income	Net income N/A	Net income (£4.3m) (FY, 2017)	Net income ($72.4m) (FY, 2016)	Net income ($43m) (FY, 2017)	Net income $154.9m (FY, 2016)
Funding
Total funding raised	Total funding raised $ 5.5m	Total funding raised N/A	Total funding raised $ 57m	Total funding raised $ 200.4m	Total funding raised N/A